Key HIV Studies Influencing My Practice Following CROI 2022

February 13-16, 2022; Virtual
Read expert faculty members’ summaries of key HIV studies from CROI 2022, including results from studies of prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.
Monica Gandhi, MD, MPH
Daniel R. Kuritzkes, MD
Babafemi Taiwo, MBBS
David A. Wohl, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 713 KB
Released: March 2, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Cepheid
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck & Co., Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings